QIAGEN N.V. (QIA.DE) Stock Fundamental Analysis
FRA:QIA - Deutsche Boerse Ag - NL0015002CX3 - Common Stock - Currency: EUR
Taking everything into account, QIA scores 5 out of 10 in our fundamental rating. QIA was compared to 15 industry peers in the Life Sciences Tools & Services industry. QIA is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. QIA has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
QIA had positive earnings in the past year.
QIA had a positive operating cash flow in the past year.
In the past 5 years QIA has always been profitable.
QIA had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With a Return On Assets value of 1.47%, QIA is not doing good in the industry: 64.71% of the companies in the same industry are doing better.
QIA has a Return On Equity of 2.34%. This is in the lower half of the industry: QIA underperforms 76.47% of its industry peers.
The Return On Invested Capital of QIA (7.09%) is better than 64.71% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.47% | ||
| ROE | 2.34% | ||
| ROIC | 7.09% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Profit Margin of QIA (4.23%) is comparable to the rest of the industry.
QIA's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 24.85%, QIA belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
QIA's Operating Margin has declined in the last couple of years.
QIA has a Gross Margin of 63.65%. This is amongst the best in the industry. QIA outperforms 94.12% of its industry peers.
In the last couple of years the Gross Margin of QIA has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 24.85% | ||
| PM (TTM) | 4.23% | ||
| GM | 63.65% |
OM growth 3Y-29.81%
OM growth 5Y-13.17%
PM growth 3Y-42.96%
PM growth 5YN/A
GM growth 3Y-8.78%
GM growth 5Y-5.78%
2. Health
2.1 Basic Checks
QIA has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
QIA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
An Altman-Z score of 3.96 indicates that QIA is not in any danger for bankruptcy at the moment.
The Altman-Z score of QIA (3.96) is better than 70.59% of its industry peers.
QIA has a debt to FCF ratio of 2.77. This is a good value and a sign of high solvency as QIA would need 2.77 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 2.77, QIA belongs to the best of the industry, outperforming 88.24% of the companies in the same industry.
QIA has a Debt/Equity ratio of 0.38. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.38, QIA is doing good in the industry, outperforming 76.47% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.38 | ||
| Debt/FCF | 2.77 | ||
| Altman-Z | 3.96 |
ROIC/WACC1
WACC7.08%
2.3 Liquidity
A Current Ratio of 3.61 indicates that QIA has no problem at all paying its short term obligations.
QIA has a better Current ratio (3.61) than 100.00% of its industry peers.
QIA has a Quick Ratio of 3.09. This indicates that QIA is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 3.09, QIA belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.61 | ||
| Quick Ratio | 3.09 |
3. Growth
3.1 Past
QIA shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 3.45%.
The Earnings Per Share has been growing by 8.09% on average over the past years. This is quite good.
QIA shows a small growth in Revenue. In the last year, the Revenue has grown by 0.66%.
Measured over the past years, QIA shows a small growth in Revenue. The Revenue has been growing by 5.32% on average per year.
EPS 1Y (TTM)3.45%
EPS 3Y-7.11%
EPS 5Y8.09%
EPS Q2Q%10.91%
Revenue 1Y (TTM)0.66%
Revenue growth 3Y-4.22%
Revenue growth 5Y5.32%
Sales Q2Q%2.36%
3.2 Future
Based on estimates for the next years, QIA will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.82% on average per year.
The Revenue is expected to grow by 8.35% on average over the next years. This is quite good.
EPS Next Y7.12%
EPS Next 2Y8.21%
EPS Next 3Y8.99%
EPS Next 5Y9.82%
Revenue Next Year3.07%
Revenue Next 2Y4.77%
Revenue Next 3Y5.54%
Revenue Next 5Y8.35%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 18.07, QIA is valued on the expensive side.
Based on the Price/Earnings ratio, QIA is valued cheaper than 100.00% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 29.35. QIA is valued slightly cheaper when compared to this.
With a Price/Forward Earnings ratio of 16.90, QIA is valued correctly.
QIA's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. QIA is cheaper than 76.47% of the companies in the same industry.
QIA's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.10.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.07 | ||
| Fwd PE | 16.9 |
4.2 Price Multiples
76.47% of the companies in the same industry are more expensive than QIA, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, QIA is valued cheaper than 82.35% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 17.05 | ||
| EV/EBITDA | 11.96 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)2.54
PEG (5Y)2.24
EPS Next 2Y8.21%
EPS Next 3Y8.99%
5. Dividend
5.1 Amount
QIA does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
FRA:QIA (3/7/2025, 7:00:00 PM)
36.51
-0.54 (-1.46%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners63.64%
Inst Owner ChangeN/A
Ins Owners0.41%
Ins Owner ChangeN/A
Market Cap7.89B
Analysts75.65
Price Target49.09 (34.46%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.67%
Min EPS beat(2)-3.85%
Max EPS beat(2)0.51%
EPS beat(4)3
Avg EPS beat(4)0.41%
Min EPS beat(4)-3.85%
Max EPS beat(4)2.78%
EPS beat(8)5
Avg EPS beat(8)0.89%
EPS beat(12)9
Avg EPS beat(12)4.08%
EPS beat(16)13
Avg EPS beat(16)5.02%
Revenue beat(2)0
Avg Revenue beat(2)-0.97%
Min Revenue beat(2)-1.92%
Max Revenue beat(2)-0.02%
Revenue beat(4)0
Avg Revenue beat(4)-1.29%
Min Revenue beat(4)-1.92%
Max Revenue beat(4)-0.02%
Revenue beat(8)0
Avg Revenue beat(8)-1.08%
Revenue beat(12)4
Avg Revenue beat(12)-0.09%
Revenue beat(16)7
Avg Revenue beat(16)0.75%
PT rev (1m)-1.6%
PT rev (3m)0.91%
EPS NQ rev (1m)-2.02%
EPS NQ rev (3m)1.7%
EPS NY rev (1m)-1.82%
EPS NY rev (3m)0.45%
Revenue NQ rev (1m)-2.93%
Revenue NQ rev (3m)-3.13%
Revenue NY rev (1m)-1.93%
Revenue NY rev (3m)-2.58%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.07 | ||
| Fwd PE | 16.9 | ||
| P/S | 4.33 | ||
| P/FCF | 17.05 | ||
| P/OCF | 12.72 | ||
| P/B | 2.4 | ||
| P/tB | 10.22 | ||
| EV/EBITDA | 11.96 |
EPS(TTM)2.02
EY5.53%
EPS(NY)2.16
Fwd EY5.92%
FCF(TTM)2.14
FCFY5.86%
OCF(TTM)2.87
OCFY7.86%
SpS8.43
BVpS15.21
TBVpS3.57
PEG (NY)2.54
PEG (5Y)2.24
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.47% | ||
| ROE | 2.34% | ||
| ROCE | 9.55% | ||
| ROIC | 7.09% | ||
| ROICexc | 9.14% | ||
| ROICexgc | 28.87% | ||
| OM | 24.85% | ||
| PM (TTM) | 4.23% | ||
| GM | 63.65% | ||
| FCFM | 25.39% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-29.81%
OM growth 5Y-13.17%
PM growth 3Y-42.96%
PM growth 5YN/A
GM growth 3Y-8.78%
GM growth 5Y-5.78%
F-Score7
Asset Turnover0.35
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.38 | ||
| Debt/FCF | 2.77 | ||
| Debt/EBITDA | 1.93 | ||
| Cap/Depr | 84.24% | ||
| Cap/Sales | 8.66% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 96.93% | ||
| Profit Quality | 600.91% | ||
| Current Ratio | 3.61 | ||
| Quick Ratio | 3.09 | ||
| Altman-Z | 3.96 |
F-Score7
WACC7.08%
ROIC/WACC1
Cap/Depr(3y)78.4%
Cap/Depr(5y)95.94%
Cap/Sales(3y)7.97%
Cap/Sales(5y)9.87%
Profit Quality(3y)273.85%
Profit Quality(5y)189.74%
High Growth Momentum
Growth
EPS 1Y (TTM)3.45%
EPS 3Y-7.11%
EPS 5Y8.09%
EPS Q2Q%10.91%
EPS Next Y7.12%
EPS Next 2Y8.21%
EPS Next 3Y8.99%
EPS Next 5Y9.82%
Revenue 1Y (TTM)0.66%
Revenue growth 3Y-4.22%
Revenue growth 5Y5.32%
Sales Q2Q%2.36%
Revenue Next Year3.07%
Revenue Next 2Y4.77%
Revenue Next 3Y5.54%
Revenue Next 5Y8.35%
EBIT growth 1Y10.42%
EBIT growth 3Y-32.77%
EBIT growth 5Y-8.55%
EBIT Next Year55.59%
EBIT Next 3Y22.21%
EBIT Next 5Y19.16%
FCF growth 1Y69.33%
FCF growth 3Y5.12%
FCF growth 5Y55.1%
OCF growth 1Y46.6%
OCF growth 3Y1.77%
OCF growth 5Y15.28%